|
Submission VLA-UNK-82501c2c
|
|
0
|
138
|
January 12, 2021
|
|
Submission EDJ-MED-2f867453
|
|
0
|
141
|
January 11, 2021
|
|
Submission MAT-POS-e69ad64a
|
|
0
|
158
|
January 11, 2021
|
|
Submission EDG-MED-0e5afe9d
|
|
0
|
136
|
January 9, 2021
|
|
Submission ALP-POS-e0fe77e5
|
|
0
|
150
|
January 8, 2021
|
|
Submission VLA-UNK-83c3754c
|
|
0
|
145
|
January 7, 2021
|
|
Submission VLA-UNK-56836b69
|
|
0
|
143
|
January 5, 2021
|
|
Submission VLA-UNK-f702bf1c
|
|
0
|
147
|
January 5, 2021
|
|
Submission MIC-UNK-16ccb665
|
|
0
|
182
|
January 5, 2021
|
|
Submission ALP-POS-84f19ead
|
|
0
|
147
|
January 4, 2021
|
|
Submission MAT-POS-cc05818f
|
|
0
|
164
|
January 4, 2021
|
|
Submission CHO-MSK-a31cca77
|
|
1
|
166
|
January 3, 2021
|
|
Submission SRE-UNK-d6ec0668
|
|
0
|
138
|
January 3, 2021
|
|
Submission SRE-UNK-f31cebfc
|
|
0
|
139
|
January 2, 2021
|
|
Submission MAT-POS-1f3f1a6f
|
|
1
|
371
|
December 31, 2020
|
|
Submission FRA-DIA-6d2bfd8c
|
|
3
|
229
|
December 30, 2020
|
|
Covid covalent inhib paper
|
|
0
|
151
|
December 30, 2020
|
|
Submission MAT-POS-89e65850
|
|
0
|
160
|
December 30, 2020
|
|
Submission KAD-UNI-80f122c8
|
|
0
|
151
|
December 30, 2020
|
|
Submission MAT-POS-c74bc7b3
|
|
0
|
137
|
December 30, 2020
|
|
Submission MAT-POS-e9e99895
|
|
0
|
157
|
December 30, 2020
|
|
Submission MAT-POS-2905de8c
|
|
0
|
146
|
December 30, 2020
|
|
Submission MAT-POS-de59a476
|
|
0
|
142
|
December 30, 2020
|
|
Submission LEE-CAM-7ab9b158
|
|
0
|
121
|
December 30, 2020
|
|
Submission VLA-UNK-7056ba74
|
|
0
|
151
|
December 29, 2020
|
|
Submission ALP-UNI-76695c4f
|
|
0
|
119
|
December 28, 2020
|
|
Submission VLA-UNK-01cc1bbb
|
|
0
|
139
|
December 26, 2020
|
|
Submission VLA-UNK-ec9ded44
|
|
0
|
137
|
December 26, 2020
|
|
Submission VLA-UNK-f2075094
|
|
0
|
134
|
December 26, 2020
|
|
Submission MAR-UNK-5c9ee000
|
|
0
|
128
|
December 26, 2020
|